Viewing nowAprogen Simvastatin Tablets 20 mg
Simvastatin 20mg
Tablet · Prescription medication
Aprogen Bio Co., Ltd.

MFDS item code 200300670 · Notified 2003.07.11 · Insurance code 645201540
Treatment of hyperlipidemia, treatment of familial hypercholesterolemia in children, and prevention of cardiovascular disease
This medication helps reduce the risk of heart disease and stroke in adult patients who are at high risk for cardiovascular diseases such as coronary heart disease, diabetes, peripheral vascular disease, and stroke. Additionally, in patients with hyperlipidemia, it contributes to improving blood lipid levels by lowering total cholesterol, LDL cholesterol, apolipoprotein B, and triglyceride levels while raising HDL cholesterol levels. It is particularly useful in pediatric patients with familial hypercholesterolemia who have difficulty controlling their condition with diet alone. This drug is used to prevent and improve these diseases.
Patients should follow a standard cholesterol-lowering diet before and during treatment with this medicine. 1. Reduction of cardiovascular risk Adult patients at high risk of coronary heart disease events due to a history of coronary heart disease, diabetes, peripheral vascular disease, stroke, or other cerebrovascular disease The recommended initial dose is simvastatin 40 mg once daily. 2. Hyperlipidemia 1) Reduction of risk in patients with hypercholesterolemia and coronary heart disease, and hyperlipidemia The usual recommended initial dose is 20 mg of this medicine once daily in the evening. Patients with mild to moderate hypercholesterolemia may start with 10 mg of this medicine. A dose of 5 ~ 40 mg of this medicine once daily in the evening is recommended. Adjust the dose appropriately based on the baseline LDL cholesterol level before treatment, the treatment goal, and the patient's response to the medicine. Measure cholesterol levels 4 weeks after starting treatment and periodically thereafter, and adjust the dose accordingly. Reduce the dose if the cholesterol level falls below the target level. Because of the increased risk of myopathy, including rhabdomyolysis, particularly during the first year of treatment, the 80 mg dose of this medicine should be used only in patients who have taken 80 mg of this medicine for 12 months or longer without evidence of muscle toxicity (see Warnings, section 1 of Precautions for Use). 2) For patients taking this medicine concomitantly with fibrates (excluding gemfibrozil and fenofibrate), amiodarone, verapamil, diltiazem, or amlodipine, and for recommended doses in certain patient groups (i.e., patients with homozygous familial hypercholesterolemia, elderly patients, and patients with renal impairment), refer to the information below (see Interactions, section 6 of Precautions for Use). (1) Use in patients with homozygous familial hypercholesterolemia In controlled clinical trials, patients with homozygous familial hypercholesterolemia received 40 mg of this medicine once daily in the evening. This medicine should be administered in combination with other lipid-lowering treatments (e.g., LDL apheresis), or if other lipid-lowering treatments are not available. (2) In elderly patients, a daily dose of 20 mg of this medicine may achieve the maximum reduction in cholesterol levels. (3) Use in patients receiving verapamil, diltiazem, or dronedarone When this medicine is administered concomitantly to patients receiving verapamil, diltiazem, or dronedarone, the dose of this medicine should not exceed 10 mg per day. (4) Use in patients receiving amiodarone, amlodipine, or ranolazine When this medicine is administered concomitantly to patients receiving amiodarone, amlodipine, or ranolazine, the dose of this medicine should not exceed 20 mg per day. (5) Concomitant administration with other lipid-lowering agents This medicine is effective when administered alone or in combination with a bile acid sequestrant. When this medicine is administered concomitantly with a fibrate (excluding gemfibrozil (see Do not administer to the following patients, section 2 of Precautions for Use) and fenofibrate), the dose of this medicine should not exceed 10 mg per day. (6) Use in patients with renal impairment As this medicine is not extensively excreted by the kidneys, no dose adjustment is necessary in patients with mild to moderate renal impairment. However, in patients with severe renal impairment, initiate treatment at 5 mg per day and monitor carefully.
Pediatric patients with heterozygous familial hypercholesterolemia (10 ~ 17 years): The recommended initial dose is 10 mg of this medicine once daily in the evening. The recommended dose range is 10 ~ 40 mg per day, and the recommended maximum dose is 40 mg per day. Adjust the dose appropriately for each patient according to the recommended treatment goal. Allow an interval of 4 weeks or longer between dose adjustments.
This drug is primarily used to lower cholesterol levels. Serious muscle-related side effects such as myopathy or rhabdomyolysis may occur when taking this medication, so caution is needed. The risk of such side effects is higher, especially when taking a high dose of 80mg, therefore, concomitant medications should be chosen at lower doses or alternatives. Patients with allergies to this medication or its ingredients, those with severely impaired liver function, pregnant or potentially pregnant women, and breastfeeding women should not take this drug. Furthermore, it should also not be administered to patients taking interacting medications such as certain antifungals, antibiotics, or immunosuppressants. Patients with poor liver or kidney function or alcohol abuse should exercise increased caution when taking this medication and should regularly check liver function and muscle condition. If symptoms such as muscle pain or weakness occur during treatment, patients should inform their doctor immediately and may need to stop taking the drug. This medication may affect liver function; hence if symptoms of hepatitis or jaundice appear, it should be discontinued immediately, and medical consultation sought. This medication may increase the risk of muscle side effects when combined with certain drugs, so it is crucial to inform healthcare providers about its use when prescribed other medications. Pregnant women should not take this drug and women planning a pregnancy should consult a doctor beforehand and use appropriate contraception. Breastfeeding women should also cease breastfeeding while taking this medication, and caution is necessary for children and the elderly regarding dosage adjustments. Regular health monitoring including liver function tests and muscle enzyme tests is necessary while taking this medication, and in case of an overdose, immediate medical attention should be sought. Store in a secure place out of reach of children and keep in the original container for safety.
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air or moisture, so it should be stored in a tightly closed container. It is best to keep it at room temperature below 30 degrees Celsius. Doing so will help maintain the drug's effectiveness and safety for a longer duration.
Brownish yellow oval film-coated tablets
30, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowSimvastatin 20mg
Tablet · Prescription medication
Aprogen Bio Co., Ltd.

Simvastatin 20mg
Tablet · Prescription medication
Jongkundang Pharmaceutical Co., Ltd.
Simvastatin 20mg
Tablet · Prescription medication
Dong-A ST Co., Ltd.

Simvastatin 20mg
Tablet · Prescription medication
Korea Hutech Pharmaceutical Co., Ltd.
Simvastatin 20mg
Tablet · Prescription medication
Yuhan Corporation

Simvastatin 40mg
Tablet · Prescription medication
Dongwha Pharmaceutical Co., Ltd.

Simvastatin 20mg
Tablet · Prescription medication
Dongsung Pharmaceutical Co., Ltd.

Simvastatin 20mg
Tablet · Prescription medication
HK inno.N Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.